BR9408219A - Comprimidos de paroxetina e um processo para a sua preparação - Google Patents

Comprimidos de paroxetina e um processo para a sua preparação

Info

Publication number
BR9408219A
BR9408219A BR9408219A BR9408219A BR9408219A BR 9408219 A BR9408219 A BR 9408219A BR 9408219 A BR9408219 A BR 9408219A BR 9408219 A BR9408219 A BR 9408219A BR 9408219 A BR9408219 A BR 9408219A
Authority
BR
Brazil
Prior art keywords
preparation
paroxetine tablets
paroxetine
tablets
Prior art date
Application number
BR9408219A
Other languages
English (en)
Inventor
Ram Dutta Pathak
David George Doughty
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10746644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9408219(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9408219A publication Critical patent/BR9408219A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9408219A 1993-12-15 1994-12-14 Comprimidos de paroxetina e um processo para a sua preparação BR9408219A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939325644A GB9325644D0 (en) 1993-12-15 1993-12-15 Novel formulation
PCT/EP1994/004164 WO1995016448A1 (en) 1993-12-15 1994-12-14 Paroxetine tablets and process to prepare them

Publications (1)

Publication Number Publication Date
BR9408219A true BR9408219A (pt) 1997-08-26

Family

ID=10746644

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9408219A BR9408219A (pt) 1993-12-15 1994-12-14 Comprimidos de paroxetina e um processo para a sua preparação

Country Status (35)

Country Link
US (1) US6113944A (pt)
EP (1) EP0734260B2 (pt)
JP (1) JP3037757B2 (pt)
KR (1) KR100367796B1 (pt)
CN (1) CN1071116C (pt)
AP (1) AP540A (pt)
AT (1) ATE180973T1 (pt)
AU (1) AU697982B2 (pt)
BG (1) BG62755B1 (pt)
BR (1) BR9408219A (pt)
CA (4) CA2178637C (pt)
CZ (1) CZ287891B6 (pt)
DE (1) DE69419033T2 (pt)
DK (1) DK0734260T4 (pt)
DZ (1) DZ1835A1 (pt)
ES (1) ES2132610T5 (pt)
FI (1) FI962445A0 (pt)
GB (1) GB9325644D0 (pt)
GR (1) GR3031047T3 (pt)
HU (1) HUT75880A (pt)
IL (1) IL111978A (pt)
MA (1) MA23395A1 (pt)
MY (1) MY112123A (pt)
NO (1) NO307366B1 (pt)
NZ (1) NZ277790A (pt)
OA (1) OA10297A (pt)
PL (1) PL314980A1 (pt)
RO (1) RO115413B1 (pt)
RU (1) RU2146141C1 (pt)
SA (1) SA94150373B1 (pt)
SI (1) SI0734260T2 (pt)
SK (1) SK282620B6 (pt)
UA (1) UA42745C2 (pt)
WO (1) WO1995016448A1 (pt)
ZA (1) ZA949900B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086053A1 (en) * 1993-12-15 2002-07-04 Smithkline Beecham Plc Formulations, tablets of paroxetine and process to prepare them
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
JP2002503248A (ja) 1997-06-10 2002-01-29 シントン・ベスローテン・フェンノートシャップ ４−フェニルピペリジン化合物
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
AU5078700A (en) * 1999-06-22 2001-01-09 Smithkline Beecham Plc Novel composition
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
EP1313474A2 (en) * 2000-08-28 2003-05-28 Synthon B.V. Paroxetine compositions and processes for making the same
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
ATE352546T1 (de) 2001-07-31 2007-02-15 Lundbeck & Co As H Kristalline zusammensetzung enthaltend escitalopram
NZ532432A (en) * 2001-10-22 2005-02-25 Synthon Bv N-formyl paroxetine compounds and their use in a synthetic route for obtaining paroxetine
AU2002359857B8 (en) * 2001-12-28 2009-01-08 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
AU2005265174A1 (en) * 2004-06-23 2006-01-26 Merck & Co., Inc. Estrogen receptor modulators
WO2006018318A1 (en) * 2004-08-18 2006-02-23 Synthon B.V. Liquid paroxetine compositions
WO2006023347A1 (en) * 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
US20060216345A1 (en) * 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
US20070112031A1 (en) * 2005-11-14 2007-05-17 Gant Thomas G Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN109771381B (zh) * 2017-11-13 2021-02-19 北京福元医药股份有限公司 一种帕罗西汀药物制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116401A (pt) * 1974-03-04 1975-09-11
ZA813205B (en) † 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
JPH06502854A (ja) * 1990-11-24 1994-03-31 ビーチャム・グループ・パブリック・リミテッド・カンパニー 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
MY112123A (en) 2001-04-30
UA42745C2 (uk) 2001-11-15
CA2178637C (en) 1997-12-23
BG100648A (bg) 1997-02-28
FI962445L (fi) 1996-06-12
NO962547D0 (no) 1996-06-14
SI0734260T1 (sl) 1999-08-31
NO962547L (no) 1996-06-14
JPH09506602A (ja) 1997-06-30
EP0734260B2 (en) 2008-07-09
HK1012285A1 (en) 1999-07-30
ES2132610T3 (es) 1999-08-16
OA10297A (en) 1997-10-07
SK75696A3 (en) 1996-11-06
EP0734260B1 (en) 1999-06-09
ES2132610T5 (es) 2008-12-16
KR100367796B1 (ko) 2003-07-22
IL111978A0 (en) 1995-03-15
DZ1835A1 (fr) 2002-02-17
HU9601665D0 (en) 1996-08-28
GB9325644D0 (en) 1994-02-16
CN1071116C (zh) 2001-09-19
DK0734260T4 (da) 2008-09-29
HUT75880A (en) 1997-05-28
NO307366B1 (no) 2000-03-27
JP3037757B2 (ja) 2000-05-08
CN1137236A (zh) 1996-12-04
SA94150373B1 (ar) 2006-05-27
US6113944A (en) 2000-09-05
AU697982B2 (en) 1998-10-22
AP540A (en) 1996-09-20
NZ277790A (en) 1998-02-26
IL111978A (en) 2000-07-16
CA2214575C (en) 1999-12-07
RO115413B1 (ro) 2000-02-28
CA2214575A1 (en) 1995-06-22
BG62755B1 (bg) 2000-07-31
CA2274387A1 (en) 1995-06-22
AP9400704A0 (en) 1995-01-31
MA23395A1 (fr) 1995-07-01
GR3031047T3 (en) 1999-12-31
SI0734260T2 (sl) 2008-12-31
CZ287891B6 (cs) 2001-03-14
DE69419033T2 (de) 1999-11-25
PL314980A1 (en) 1996-09-30
RU2146141C1 (ru) 2000-03-10
CZ176396A3 (en) 1996-09-11
AU1314595A (en) 1995-07-03
ZA949900B (en) 1995-10-10
ATE180973T1 (de) 1999-06-15
CA2178637A1 (en) 1995-06-22
CA2274389C (en) 2004-09-14
DK0734260T3 (da) 1999-11-15
FI962445A7 (fi) 1996-06-12
SK282620B6 (sk) 2002-10-08
SA94150373A (ar) 2005-12-03
WO1995016448A1 (en) 1995-06-22
EP0734260A1 (en) 1996-10-02
FI962445A0 (fi) 1996-06-12
DE69419033D1 (de) 1999-07-15
CA2274389A1 (en) 1995-06-22

Similar Documents

Publication Publication Date Title
PT909327E (pt) Eritromicinas e processo para a sua preparacao
PT799866E (pt) Negro-de-fumo e processo para a sua preparacao
BR9505940A (pt) Comprimido mastigável e processo para sua preparação
PT750907E (pt) Formulacoes de vacinas estaveis para administracao parenterica metodo para a sua utilizacao e processo para a sua preparacao
BR9006848A (pt) Copolimero de policarbonato-polidimetilsiloxano e processo para a sua producao
BR9503638A (pt) Composto processo para sua produção e formulação farmacêutica
BR9408463A (pt) Novos derivados de ginkgolide e processo para sua preparação
PT815074E (pt) Compostos de o-carbamoil-(d)-fenilalanilol e processo para a sua preparacao
BR9707839A (pt) Primido-Ú5,4-D¾-primidas medicamentos contendo esses compostos sua aplicação e processo para a sua preparação
FI962445L (fi) Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
BR9612135A (pt) Taxóides processo para sua preparação e composiç o farmacêutica
PT100316A (pt) Anticoagulantes e processo para a sua preparacao
PT100917A (pt) Heteroarilaminas que actuam como novos inibidores de acetilcolinesterase e processo para a sua preparacao
BR9605354A (pt) Composto composição farmacêutica processo para a produção do composto e uso
BR9611466A (pt) Vacinas de tumores e processo para a sua preparação
BR9606396A (pt) Derivados de camptotecin substituídos e processo para sua preparação
PT101182A (pt) Antagonistas de ltb4 a base de benzopiranos e relacionados, e processo para a sua preparacao
PT900253E (pt) Composicoes de betume e um processo para a sua preparacao
BR9001614A (pt) Avental de cirurgia e processo para sua fabricacao
BR9206950A (pt) Composição farmacêutica e processo para sua preparação
BR9602983A (pt) Gel e processo para sua preparação
BR9305296A (pt) Cárter e processo para a sua fabricação
BR9608374A (pt) Processo para a prepara-Æo de cloridrato de lercanidipina
PT101183A (pt) Antagonistas de ltb4 a base de benzopirano e afins e processo para a sua preparacao
BR9600289A (pt) Material de sinterização e processo para a sua preparação

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal